DISEASE ACTIVITY AND CLINICAL RESPONSE EARLY IN THE COURSE OF TREATMENT PREDICT LONG-TERM OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL
Author(s):
Heijde, D. van der; Deodhar, A.; Davies, O.; Nurminen, T.; Rudwaleit, M.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, p. 714-715
